• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Cala Health

Cala Health wins FDA breakthrough nod for tremor treating therapy

October 22, 2020 By Sean Whooley

Cala Health announced today that it received FDA breakthrough device designation for its Cala Trio treatment for action tremors in people with Parkinson’s disease. Burlingame, Calif.-based Cala Health’s Cala Trio is FDA cleared to relieve hand tremors from essential tremor (ET), but the company is now nearing the initiation of clinical trials to evaluate the […]

Filed Under: Digital Health, Featured, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Cala Health, FDA

Cala Health touts results of real-world tremor study

September 14, 2020 By Sean Whooley

Cala Health today touted data demonstrating that its Cala Trio therapy is safe and effective in improving essential tremor in patients. Burlingame, Calif.-based Cala Health said in a news release that the data for the wearable technology came from use at home, unsupervised and under real-world conditions, further validating the results reported in the Prospect […]

Filed Under: Clinical Trials, Health Technology, Neurological, Neuromodulation/Neurostimulation, Software / IT Tagged With: Cala Health

MedTech 100 roundup: Stocks were practically unchanged last week

August 24, 2020 By Sean Whooley

Despite plenty of ups and downs coming in the stock market for the medtech industry, there was hardly any movement from week to week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.6 points at the end of last week (Aug. 21). Overall, medtech stocks saw […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bayer, Cala Health, cochlear, conformis, CureVac, Fractyl Laboratories, Johnson and Johnson, momentapharmaceuticals, Principia Biopharma, S&P, Sanofi, Stryker, Teva Pharmaceuticals

DTW Podcast: Can Fractyl Labs and Cala Health go where only drugs have gone before?

August 21, 2020 By Tom Salemi

In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer. We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is […]

Filed Under: Bioelectronic Medicine, Biotech, Device Talks Podcasts, Diabetes, Featured, Initial Public Offering (IPO) Tagged With: Avail Medsystems, Bayer, Cala Health, ClearMask, CureVac, Fractyl Laboratories, Thermo Fisher Scientific

Cala cites positive data in Trio tremor trial

August 17, 2020 By Tom Salemi

Bioelectronic company Cala Health released positive data from its ongoing PROSPECT trial demonstrating that a majority of patients using its  FDA-cleared Cala Trio device reported a reduction in hand tremors. The study — published in Tremor and Other Hyperkinetic Movements — enrolled 263 patients with essential tremor across 26 sites. Patients wore the Trio on […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured Tagged With: Abbott, Cala Health, Intuitive Surgical, Novartis

CEO Ryan explains how Cala Health is building bioelectronic medicine business

June 12, 2020 By Tom Salemi

In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health. Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala […]

Filed Under: Bioelectronic Medicine, Device Talks Podcasts, Neurological Tagged With: Alphabet (Google), Cala Health, Johnson and Johnson, Verb Surgical

Cala Health touts top-line data on Trio wearable for essential tremor

September 26, 2019 By Sean Whooley

Cala Health yesterday presented top-line data from a study of its Cala Trio therapy for treating essential tremor. Trio is a wrist-worn neuromodulation device designed to stimulate nerves responsible for the tremor to provide symptomatic relief. Burlingame, Calif.-based Cala Health said its Prospect trial, which is touts as the largest ever conducted for essential tremor, […]

Filed Under: Clinical Trials, Neurological, Neuromodulation/Neurostimulation Tagged With: Cala Health

Innoblative taps ex-Lumicell chief Londy for CEO | Personnel Moves, Sept. 13, 2019

September 13, 2019 By Brad Perriello

Innoblative Designs last week named former Lumicell chief executive Kelly Londy as its new CEO. Apart from her two-year stint at the Lumicell helm, Londy was COO at Accuray (NSDQ:ARAY) and worked at GE Healthcare and Philips Healthcare. “Innoblative’s Sira RF ablation device offers unique capabilities that address shortcomings in the current advanced energy surgical market,” […]

Filed Under: Business/Financial News, Featured Tagged With: Alpha Tau Medical, Cala Health, Genetesis, Innoblative Designs, IRRAS, MiMedx Group Inc., Obalon Therapeutics, Orchestra BioMed, Ozop Surgical, Personnel Moves, Shine Medical Technologies

Cala Health licenses MGH-developed neuromod tech

March 14, 2019 By Fink Densford

Cala Health said this week it inked a deal to license technology from Partners Healthcare and its affiliate Massachusetts General Hospital intended to improve the company’s non-invasive neuromodulation platform for investigating and treating chronic diseases. The licensed technology was developed from research on transcutaneous vagus nerve stimulation and respiratory-gated vagal afferent nerve stimulation at a […]

Filed Under: Neurological, Neuromodulation/Neurostimulation, Research & Development Tagged With: Cala Health

Cala Health launches trial for Cala Two neurostim device for essential tremor

January 17, 2019 By Brad Perriello

Cala Health last month launched a clinical trial of the latest version of its wearable neurostimulator for treating essential tremor, eyeing extended use of the wrist-worn device. The Burlingame, Calif.-based company won de novo clearance from the FDA last April for the Cala One device for transient relief in adults with essential tremor. The 500-patient, single-arm […]

Filed Under: Clinical Trials, Neuromodulation/Neurostimulation Tagged With: Cala Health

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS